ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cook, S.
Right arrow Articles by Scherrer, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cook, S.
Right arrow Articles by Scherrer, U.
Eur Respir J 2003; 21:770-773
Copyright ©ERS Journals Ltd 2003


Increased eNO and pulmonary iNOS expression in eNOS null mice

S. Cook1,2, P. Vollenweider1,2, B. Ménard2, M. Egli1,2, P. Nicod1 and U. Scherrer1,2

1 Dept of Internal Medicine, and 2 Botnar Centre for Clinical Research, University Hospital, Lausanne, Switzerland

CORRESPONDENCE: U. Scherrer, Dept of Internal Medicine, BH 10.642, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland. Fax: 41 21 3140451. E-mail: Urs.Scherrer@chuv.hospvd.ch

Keywords: endothelial dysfunction, exhaled nitric oxide, nitric oxide synthase, nitrite/nitrate plasma concentration, pulmonary circulation, pulmonary hypertension

Received: December 27, 2002
Accepted January 13, 2003

This study was supported by grants from the Swiss National Science Foundation (Bern, Switzerland), International Olympic Committee (Lausanne, Switzerland), Emma Muschamp Foundation (Lausanne) and Placide Nicod Foundation (Lausanne). This work was presented, in part, at the European Respiratory Society Annual Congress 2000, Florence, Italy, August 30–September 2, 2000, and at Experimental Biology 2001, Orlando, FL, USA, March 31–April 4, 2001.

Nitric oxide (NO) is a major regulatory molecule of the cardiovascular system; however, measurement of vascular NO synthesis in vivo represents a major challenge. NO stemming from the lower respiratory tract has been used as a marker of vascular endothelial function. Experimental evidence for this concept is lacking. Therefore, the aim of the present study was to investigate this relationship.

Lower respiratory tract exhaled NO concentration, together with systemic and pulmonary artery pressure, was measured in endothelial nitric oxide synthase (NOS) (eNOS) null mice (eNOS-/-). Similar studies were performed in inducible NOS (iNOS) null mice (iNOS-/-).

Defective endothelial NO synthesis in eNOS-/- mice (evidenced by systemic and pulmonary hypertension) was associated with augmented exhaled NO levels (12.5±1.9 versus 9.8±1.2 parts per billion (ppb), eNOS-/- versus wild type), whereas normal endothelial NO synthesis in iNOS-/- mice was associated with decreased exhaled NO levels (4.3±1.5 ppb). Augmented exhaled NO levels in eNOS-/- mice were associated with upregulation of iNOS expression in the lung.

These results indicate that inducible nitric oxide synthase is a major determinant of gaseous nitric oxide production in the lung, and lower respiratory tract exhaled nitric oxide does not always represent a marker of vascular endothelial nitric oxide synthesis.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Maarsingh, A. B. Zuidhof, I. S. T. Bos, M. van Duin, J.-L. Boucher, J. Zaagsma, and H. Meurs
Arginase Inhibition Protects against Allergen-induced Airway Obstruction, Hyperresponsiveness, and Inflammation
Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 565 - 573.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. Meurs, R. Gosens, and J. Zaagsma
Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models
Eur. Respir. J., August 1, 2008; 32(2): 487 - 502.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. Leblais, E. Delannoy, F. Fresquet, H. Begueret, N. Bellance, S. Banquet, C. Allieres, L. Leroux, C. Desgranges, A. Gadeau, et al.
{beta}-adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxide-dependent {beta}2 component in pulmonary hypertension
Cardiovasc Res, January 1, 2008; 77(1): 202 - 210.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. A. Miller, A. A. Hislop, P. J. Vallance, and S. G. Haworth
Deletion of the eNOS gene has a greater impact on the pulmonary circulation of male than female mice
Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L299 - L366.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
C Lane, D Knight, S Burgess, P Franklin, F Horak, J Legg, A Moeller, and S Stick
Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath
Thorax, September 1, 2004; 59(9): 757 - 760.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
F L M Ricciardolo, M C Timmers, J K Sont, G Folkerts, and P J Sterk
Effect of bradykinin on allergen induced increase in exhaled nitric oxide in asthma
Thorax, October 1, 2003; 58(10): 840 - 845.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.